Beyond unimodal analysis: Multimodal ensemble learning for enhanced assessment of atherosclerotic disease progression

Valerio Guarrasi1, Amanda Bertgren2, Ulf Näslund3

  • 1Research Unit of Artificial Intelligence and Computer Systems, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.

Insights

This study introduces a new multimodal AI framework to detect early atherosclerosis by combining clinical data and ultrasound images, improving cardiovascular risk assessment beyond current methods.

Area of Science:

  • Cardiovascular Medicine
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Atherosclerosis is a major cause of cardiovascular disease, leading to plaque rupture and stroke.
  • Current risk scores (e.g., Framingham) and ultrasound markers (e.g., carotid intima-media thickness) have limited sensitivity for early detection.
  • Existing models often analyze clinical or imaging data separately, lacking a comprehensive multimodal approach.

Purpose of the Study:

  • To develop and evaluate a multimodal ensemble learning framework for assessing atherosclerosis severity, particularly in its sub-clinical stages.
  • To integrate features from clinical risk factors and ultrasound imaging for a more accurate cardiovascular risk assessment.
  • To measure the efficacy of multimodal models in evaluating vascular aging (plaque presence, vascular age) over six years.

Main Methods:

  • Development of a multimodal ensemble learning framework using multi-objective optimization for performance and diversity.
  • Integration of clinical risk factors and ultrasound image-derived features.
  • Application of eXplainable Artificial Intelligence (XAI) techniques to understand model drivers and identify subject subgroups.

Main Results:

  • The multimodal framework effectively integrates diverse data sources for improved atherosclerosis assessment.
  • The study demonstrates the efficacy of combining clinical and imaging data for evaluating vascular aging.
  • XAI techniques provided insights into key predictive features and distinct patient subgroups.

Conclusions:

  • Multimodal ensemble learning offers a superior approach to assessing early-stage atherosclerosis compared to single-modality methods.
  • Combining clinical and imaging data enhances the prediction of vascular aging and cardiovascular risk.
  • The developed framework and XAI analysis provide valuable tools for personalized cardiovascular risk stratification.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
82
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
34